Get all your news in one place.
100's of premium titles.
One app.
Start reading
Foreign Policy
Foreign Policy
Politics
Michael Hirsh, Joshua Tallis, David Knoll

Can Biden’s Vaccine Patent Waiver End the Pandemic?

U.S. President Joe Biden leaves after he delivered remarks on the COVID-19 response and vaccination program during an event at the White House in Washington on May 4. Alex Wong/Getty Images

U.S. President Joe Biden is winning widespread praise from health experts for endorsing a six-month-old proposal to waive the pharmaceutical industry’s intellectual property (IP) rights on COVID-19 vaccines. But several questions remain, including how quickly Wednesday’s decision will translate to more vaccines in the developing world and whether other rich countries will join the United States in supporting Biden’s plan.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.